ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1722

TLR4 and TLR7 Are Required for Gadolinium Based Contrast Agent Induction of Dermal and Pulmonary Fibrosis in an Adenine-Induced Model of Chronic Renal Failure

Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Collagen, fibrosis, innate immunity, nephrogenic fibrosing dermopathy and renal disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose : Nephrogenic Systemic Fibrosis (NSF) is a generalized progressive fibrotic disorder that occurs in some patients with renal insufficiency exposed to various gadolinium based contrast agents (GdBCA).  TLR4 and TLR7 signaling has been reported to be necessary for the in vitro establishment of a profibrotic phenotype by the GdBCA Omniscan in normal human macrophages. In this study, we examined the role of TLR4 and TLR7 in the development of NSF-like lesions in vivoin mice with renal failure induced by a high adenine diet following exposure to GdBCA by intratracheal instillation.

Methods:

Chronic renal failure was induced in normal mice and in TLR4 and TLR7 knockout  (TLR4 KO) and (TLR7 KO) mice by ad libitumfeeding of a standard rodent diet supplemented with 3% adenine for 30 days.  Two weekly doses of either the GdBCA Omniscan (100 µL of a 0.5 M solution, corresponding to a 0.05 mmol/kg dose) or an equal volume of normal saline were administered by intratracheal instillation to mice with either normal renal function or with adenine diet-induced chronic renal failure.  Mice were sacrificed 56 days after the final instillation and tissues were isolated for analysis of the severity of tissue fibrosis by histological examination (hematoxyllin/eosin and Masson’s trichrome stains) and by assays of collagen content employing a standard hydroxyproline assay of hydrolyzed tissue samples.

Results: Histopathology studies showed mononuclear cell infiltration and severe peribronchial fibrosis and moderate diffuse interstitial fibrosis in lungs isolated from adenine-fed control (C57BL6/J) mice instilled with Omniscan. In contrast, lungs from adenine-fed TLR4 KO or TLR7 KO mice maintained normal lung histology.  Mice of all three strains with normal renal function instilled with Omniscan and mice with either normal or ablated renal function instilled with saline also demonstrated no fibrosis. Hydroxyproline content was increased ~3 fold in the lungs of Omniscan-instilled wild type mice with adenine diet-induced renal failure. In contrast, the lungs of Omniscan-instilled TLR4 KO and TLR7 KO mice with or without renal failure had normal hydroxyproline levels.

Conclusion:

The present study demonstrates for the first time in vivo that the ability to induce significant tissue fibrosis and increased collagen deposition in mice with adenine induced renal failure exposed to the gadolinium contrast agent Omniscan requires signaling through TLR4 and TLR7.  These results indicate that targeting of TLR signaling could be a valuable strategy to prevent or treat NSF and other TLR-mediated chemically-induced fibrotic disorders.


Disclosure:

P. J. Wermuth,
None;

S. A. Jimenez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr4-and-tlr7-are-required-for-gadolinium-based-contrast-agent-induction-of-dermal-and-pulmonary-fibrosis-in-an-adenine-induced-model-of-chronic-renal-failure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology